glutathione for parkinson's patients – Getting the k'NAC'k of disease – The Science of Parkinson's intranasal glutathione in parkinson's disease

August 3, 2026 Explore how BPC-157 capsules are used in preclinical research, including stability, delivery methods, and what studies reveal about this peptide format

Cagrilintide is not for everyone, and candidacy is confirmed with a full evaluation

23 After 6 months of supplementation, 74% in the B12 group had reached no aphthous ulcer status, compared with 32% in the placebo group

Nucleic Acids Res (2015) 43(1):37384

No longer confined to pro athletes or experimental clinics, peptide-based medicine is entering the mainstream and Diamond Health is proud to be on the forefront of this transformation

Schedule an initial discovery call online or call our office to connect with a New Patient Onboarding Specialist